Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Bio-Techne	CRISPR Therapeutics	argenx	QIAGEN	Repligen
Symbol	NASDAQ:TECH	NASDAQ:CRSP	NASDAQ:ARGX	NYSE:QGEN	NASDAQ:RGEN
Price Information
Current Price	$376.00	$130.15	$335.18	$50.43	$212.69
52 Week Range	Buy	Buy	Buy	Buy	Buy
MarketRank™
Overall Score	1.8	1.5	1.1	1.7	1.5
Analysis Score	1.3	3.3	2.3	3.3	1.5
Community Score	2.3	2.7	2.5	2.3	2.6
Dividend Score	1.7	0.0	0.0	0.0	0.0
Ownership Score	1.7	1.7	0.8	0.8	1.7
Earnings & Valuation Score	1.9	0.0	0.0	1.9	1.9
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Buy	Buy
Consensus Price Target	$352.30	$150.20	$286.82	$56.37	$204.75
% Upside from Price Target	-6.30% downside	15.41% upside	-14.43% downside	11.78% upside	-3.73% downside
Trade Information
Market Cap	$14.45 billion	$9.82 billion	$16.12 billion	$11.47 billion	$12.14 billion
Beta	1.13	2.37	1	0.41	0.94
Average Volume	195,692	2,486,028	213,291	965,467	379,766
Sales & Book Value
Annual Revenue	$738.69 million	$289.59 million	$78.17 million	$1.53 billion	$270.24 million
Price / Sales	19.75	33.90	202.99	7.52	43.11
Cashflow	$6.99 per share	$0.84 per share	N/A	$2.51 per share	$1.44 per share
Price / Cash	53.77	154.11	N/A	20.07	147.51
Book Value	$36.13 per share	$17.02 per share	$30.88 per share	$11.14 per share	$20.36 per share
Price / Book	10.41	7.65	10.85	4.53	10.45
Profitability
Net Income	$229.30 million	$66.86 million	$-182,520,000.00	$-41,460,000.00	$21.41 million
EPS	$3.86	$1.17	($4.73)	$1.43	$1.07
Trailing P/E Ratio	60.16	N/A	N/A	62.26	259.38
Forward P/E Ratio	64.27	N/A	N/A	20.58	128.13
P/E Growth	7.23	N/A	N/A	1.29	4.18
Net Margins	32.69%	-273.10%	N/A	11.18%	13.40%
Return on Equity (ROE)	12.20%	-20.72%	N/A	17.51%	6.58%
Return on Assets (ROA)	8.09%	-18.35%	N/A	8.44%	5.00%
Dividend
Annual Payout	$1.28	N/A	N/A	N/A	N/A
Dividend Yield	0.34%	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	33.16%	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	1 Years	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.22%	N/A	N/A	0.52%	0.21%
Current Ratio	5.14%	16.53%	9.90%	1.46%	13.67%
Quick Ratio	4.13%	16.53%	9.87%	1.22%	12.13%
Ownership Information
Institutional Ownership Percentage	93.75%	66.43%	54.21%	43.64%	84.33%
Insider Ownership Percentage	3.80%	17.10%	N/A	9.00%	1.70%
Miscellaneous
Employees	2,300	304	186	5,300	761
Shares Outstanding	38.80 million	75.43 million	47.34 million	227.75 million	54.77 million
Next Earnings Date	4/29/2021 (Estimated)	4/27/2021 (Estimated)	3/4/2021 (Confirmed)	5/5/2021 (Estimated)	5/5/2021 (Estimated)
Optionable	Optionable	Optionable	Optionable	Optionable	Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources